RGNX
8.21 USD
+0.12%
Today
-0.12%
1D
Market is open
Sun
Closed
Mon
3:00 AM ~ 12:00 PM
Tue
12:00 AM ~ 12:00 PM
Wed
12:00 AM ~ 12:00 PM
Thu
12:00 AM ~ 12:00 PM
Fri
12:00 AM ~ 12:00 PM
Sat
Closed
Information
Name
Regenxbio Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0183%
Overnight Fees Sell
0.0016%
Market Cap
707.66M
Avg Daily Volume
1.94M
52 Week High
16.19 USD
52 Week Low
5.455 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01830% | $(0.183) |
| SELLS | 0.00160% | $0.016 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202 for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 and with Nippon Shinyaku Co., Ltd. to develop RGX-121 and RGX-111 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
Top News
Regenxbio
-0.12%
REGENXBIO says FDA places RGX-121 on clinical hold; BLA resubmission not expected soon
tradingview.com
55m ago
Regenxbio
-0.12%
RGNX Stock On Track For Worst Day In Over Three Months — BofA Says Buy Despite ‘Disappointing’ FDA Hold On Gene Therapy
tradingview.com
3h ago
Regenxbio
-0.12%
Invesco
+0.28%
SanDisk.Corp
-0.23%
Marvell-Technology
+0.03%
WesternDig
-0.13%
MicronTech
-0.01%
Seagate
+0.07%
Intel
-0.03%
LamRes
+0.22%
AMD.Inc
+0.00%
NVIDIA
+0.03%
Arm.Holdings
+0.14%
DR_Horton
-0.43%
Lennar
-0.16%
Applied.Optoelectronics
+0.00%
Visa
+0.15%
MasterCard
+0.13%
AppliedMat
-0.02%
BuildersFirstSource
-0.54%
Cleveland_Cliffs
+0.00%
DIA_CFD
-0.10%
Darden
+2.83%
KB_Home
-0.94%
KLATencor
+0.10%
MicrochipT
+0.16%
Nucor
-0.36%
NXP
+1.79%
PulteGroup
+0.20%
SPY_CFD
+0.00%
StateStreet
+2.24%
SteelDyn
+2.86%
TollBrothers
-0.07%
Stocks Pressured by Weakness in Chipmakers and AI-Infrastructure Stocks
tradingview.com
8h ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
